Breaking News Instant updates and real-time market news.

SNY

Sanofi

$52.42 /

+0.34 (+0.65%)

08:37
09/21/20
09/21
08:37
09/21/20
08:37

Sanofi presents trial data for investigational use of Libtayo in NSCLC

Positive pivotal trial data for the investigational use of PD-1 inhibitor Libtayo in first-line locally advanced or metastatic non-small cell lung cancer were shared in a presentation at the European Society for Medical Oncology Virtual Congress 2020. The trial compared Libtayo monotherapy to platinum-doublet chemotherapy in patients whose tumor cells expressed PD-L1, including those whose cancers had confirmed PD-L1 expression of greater than or equal to50%.These results form the basis of regulatory submissions, including in the U.S. and European Union. The late-breaking ESMO presentation expands on topline results shared in April. In the overall trial population, the median follow-up was 13 months for both Libtayo and chemotherapy. Among these patients, Libtayo demonstrated the following results compared to chemotherapy: 32% reduced risk of death. 22-month median overall survival compared to 14 months. 41% reduced risk of disease progression. The median progression-free survival was 6.2 months compared to 5.6 months. 37% objective response rate compared to 21% ORR. A prespecified analysis of data from patients whose cancers had confirmed PD-L1 expression greater than or equal to50% was also conducted. In this group, the median follow-up was 11 months for both Libtayo and chemotherapy, and Libtayo demonstrated the following results compared to chemotherapy: 43% reduced risk of death. Median OS was not yet reached compared to 14 months. 46% reduced risk of disease progression. The median PFS was 8 months compared to 6 months. 39% ORR compared to 20% ORR. The trial also found a direct correlation between tumor response and PD-L1 expression level in Libtayo-treated patients. The ORR was highest in tumors with greater than or equal to90% PD-L1 expression, with target tumors shrinking by more than 40% after 6 months of treatment on average. This correlation with PD-L1 expression level was not observed with chemotherapy. In the overall trial population, the median duration of exposure to Libtayo was 27 weeks and 18 weeks for chemotherapy. Overall adverse events occurred in 88% of Libtayo patients and 94% of chemotherapy patients. Grade 3 or higher AEs occurred in 37% of Libtayo patients and 49% of chemotherapy patients. Immune-mediated AEs were reported in 17% of Libtayo patients and included hypothyroidism, hyperthyroidism, pneumonitis, hepatitis, skin adverse reaction, arthritis, increased blood thyroid stimulating hormone, thyroiditis, colitis, nephritis and peripheral neuropathy. Treatment discontinuation due to an AE occurred in 6% of Libtayo patients and 4% of chemotherapy patients. No new Libtayo safety signals were observed. Libtayo is being jointly developed by Regeneron and Sanofi under a global collaboration agreement. The use of Libtayo to treat advanced NSCLC is investigational and has not been fully evaluated by any regulatory authority.

  • 21

    Sep

  • 23

    Sep

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
08/18/20 SVB Leerink
Principia Biopharma downgraded to Market Perform at SVB Leerink

TODAY'S FREE FLY STORIES

Hot Stocks
Sanderson Farms up 6% to $129.60 after announcing rejection of takeover bid  15:21
10/29/20
10/29
15:21
10/29/20
15:21
SAFM

Sanderson Farms

$128.19 /

+5.23 (+4.25%)

 
ShowHide Related Items >><<
SAFM Sanderson Farms
$128.19 /

+5.23 (+4.25%)

SAFM Sanderson Farms
$128.19 /

+5.23 (+4.25%)

10/19/20 BMO Capital
Sanderson Farms price target lowered to $132 from $150 at BMO Capital
09/10/20
Fly Intel: Top five analyst upgrades
09/10/20 Goldman Sachs
Sanderson Farms upgraded to Buy from Neutral at Goldman Sachs
09/08/20 Seaport Global
Sanderson Farms initiated with a Neutral at Seaport Global
SAFM Sanderson Farms
$128.19 /

+5.23 (+4.25%)

SAFM Sanderson Farms
$128.19 /

+5.23 (+4.25%)

SAFM Sanderson Farms
$128.19 /

+5.23 (+4.25%)

Hot Stocks
Sanderson says unsolicited, 'opportunistic' $142 per share bid rejected » 15:19
10/29/20
10/29
15:19
10/29/20
15:19
SAFM

Sanderson Farms

$128.21 /

+5.25 (+4.27%)

, TSN

Tyson Foods

$57.82 /

+1.1 (+1.94%)

Sanderson Farms (SAFM)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

TSN Tyson Foods
$57.82 /

+1.1 (+1.94%)

SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

10/19/20 BMO Capital
Sanderson Farms price target lowered to $132 from $150 at BMO Capital
09/10/20
Fly Intel: Top five analyst upgrades
09/10/20 Goldman Sachs
Sanderson Farms upgraded to Buy from Neutral at Goldman Sachs
09/08/20 Seaport Global
Sanderson Farms initiated with a Neutral at Seaport Global
TSN Tyson Foods
$57.82 /

+1.1 (+1.94%)

08/26/20 JPMorgan
Tyson Foods price target raised to $70 from $63 at JPMorgan
08/05/20
Fly Intel: Top five analyst downgrades
08/05/20 Credit Suisse
Tyson Foods downgraded to Neutral from Outperform at Credit Suisse
07/28/20 Seaport Global
Tyson Foods initiated with a Neutral at Seaport Global
SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

TSN Tyson Foods
$57.82 /

+1.1 (+1.94%)

SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

TSN Tyson Foods
$57.82 /

+1.1 (+1.94%)

SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

TSN Tyson Foods
$57.82 /

+1.1 (+1.94%)

TSN Tyson Foods
$57.82 /

+1.1 (+1.94%)

Options
Bloom Energy options imply 21.1% move in share price post-earnings » 15:19
10/29/20
10/29
15:19
10/29/20
15:19
BE

Bloom Energy

$14.77 /

+0.18 (+1.23%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BE Bloom Energy
$14.77 /

+0.18 (+1.23%)

BE Bloom Energy
$14.77 /

+0.18 (+1.23%)

07/29/20 Credit Suisse
Weakness in Bloom Energy shares 'well overdone,' says Credit Suisse
07/16/20 Morgan Stanley
Bloom Energy adds upside potential with hydrogen entry, says Morgan Stanley
05/28/20 JPMorgan
Bloom Energy price target raised to $17 from $14 at JPMorgan
05/12/20 Morgan Stanley
Bloom Energy's underlying demand still appears strong, says Morgan Stanley
BE Bloom Energy
$14.77 /

+0.18 (+1.23%)

  • 15
    Oct
  • 02
    Oct
BE Bloom Energy
$14.77 /

+0.18 (+1.23%)

BE Bloom Energy
$14.77 /

+0.18 (+1.23%)

BE Bloom Energy
$14.77 /

+0.18 (+1.23%)

Technical Analysis
NASDAQ market internals summary » 15:17
10/29/20
10/29
15:17
10/29/20
15:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
Sanderson Farms says no proposal received from Tyson Foods and Durational  15:16
10/29/20
10/29
15:16
10/29/20
15:16
SAFM

Sanderson Farms

$128.21 /

+5.25 (+4.27%)

, TSN

Tyson Foods

$57.76 /

+1.04 (+1.83%)

 
ShowHide Related Items >><<
SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

TSN Tyson Foods
$57.76 /

+1.04 (+1.83%)

SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

10/19/20 BMO Capital
Sanderson Farms price target lowered to $132 from $150 at BMO Capital
09/10/20
Fly Intel: Top five analyst upgrades
09/10/20 Goldman Sachs
Sanderson Farms upgraded to Buy from Neutral at Goldman Sachs
09/08/20 Seaport Global
Sanderson Farms initiated with a Neutral at Seaport Global
TSN Tyson Foods
$57.76 /

+1.04 (+1.83%)

08/26/20 JPMorgan
Tyson Foods price target raised to $70 from $63 at JPMorgan
08/05/20
Fly Intel: Top five analyst downgrades
08/05/20 Credit Suisse
Tyson Foods downgraded to Neutral from Outperform at Credit Suisse
07/28/20 Seaport Global
Tyson Foods initiated with a Neutral at Seaport Global
SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

TSN Tyson Foods
$57.76 /

+1.04 (+1.83%)

SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

TSN Tyson Foods
$57.76 /

+1.04 (+1.83%)

SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

TSN Tyson Foods
$57.76 /

+1.04 (+1.83%)

TSN Tyson Foods
$57.76 /

+1.04 (+1.83%)

Hot Stocks
Sanderson Farms rejects $142 unsolicited takeover bid from Durational Capital  15:16
10/29/20
10/29
15:16
10/29/20
15:16
SAFM

Sanderson Farms

$128.21 /

+5.25 (+4.27%)

 
ShowHide Related Items >><<
SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

10/19/20 BMO Capital
Sanderson Farms price target lowered to $132 from $150 at BMO Capital
09/10/20
Fly Intel: Top five analyst upgrades
09/10/20 Goldman Sachs
Sanderson Farms upgraded to Buy from Neutral at Goldman Sachs
09/08/20 Seaport Global
Sanderson Farms initiated with a Neutral at Seaport Global
SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

SAFM Sanderson Farms
$128.21 /

+5.25 (+4.27%)

Technical Analysis
NYSE market internals summary » 15:16
10/29/20
10/29
15:16
10/29/20
15:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Recommendations
Piper Sandler still likes Progenity despite 'spooky' Q3 miss » 15:15
10/29/20
10/29
15:15
10/29/20
15:15
PROG

Progenity

$6.71 /

-1.07 (-13.75%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PROG Progenity
$6.71 /

-1.07 (-13.75%)

PROG Progenity
$6.71 /

-1.07 (-13.75%)

10/23/20 BTIG
Progenity initiated with a Buy at BTIG
09/25/20 Piper Sandler
Progenity shares remain undervalued, says Piper Sandler
08/17/20 Piper Sandler
ACOG recommendation 'extremely' positive for Natera and Progenity, says Piper
08/17/20 Baird
ACOG bulletin positive for prenatal testing players, says Baird
PROG Progenity
$6.71 /

-1.07 (-13.75%)

  • 19
    Jun
PROG Progenity
$6.71 /

-1.07 (-13.75%)

Hot Stocks
Disney shares up 3% after Netflix raises prices for U.S. plans » 15:13
10/29/20
10/29
15:13
10/29/20
15:13
DIS

Disney

$121.46 /

+2.96 (+2.50%)

, NFLX

Netflix

$484.67 /

-1.2 (-0.25%)

Shares of Disney (DIS)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$121.46 /

+2.96 (+2.50%)

NFLX Netflix
$484.67 /

-1.2 (-0.25%)

DIS Disney
$121.46 /

+2.96 (+2.50%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 RBC Capital
EPR Properties downgraded to Sector Perform from Outperform at RBC Capital
10/13/20 Morgan Stanley
Disney reorg 'leaves little doubt' about DTC commitment, says Morgan Stanley
10/13/20 Loop Capital
Disney upgraded to Buy from Hold at Loop Capital
NFLX Netflix
$484.67 /

-1.2 (-0.25%)

10/26/20 Wells Fargo
Netflix narrative to focus less on subs, more on profitability, says Wells Fargo
10/21/20 JPMorgan
Netflix weakness on earnings a buying opportunity, says JPMorgan
10/21/20 KeyBanc
KeyBanc sees Netflix stock weakness as 'an overreaction'
10/21/20 Wells Fargo
Netflix price target raised to $510 from $470 at Wells Fargo
DIS Disney
$121.46 /

+2.96 (+2.50%)

NFLX Netflix
$484.67 /

-1.2 (-0.25%)

DIS Disney
$121.46 /

+2.96 (+2.50%)

NFLX Netflix
$484.67 /

-1.2 (-0.25%)

DIS Disney
$121.46 /

+2.96 (+2.50%)

NFLX Netflix
$484.67 /

-1.2 (-0.25%)

DIS Disney
$121.46 /

+2.96 (+2.50%)

NFLX Netflix
$484.67 /

-1.2 (-0.25%)

Hot Stocks
Netflix up 4% after U.S. prices raised for top tier plans » 15:11
10/29/20
10/29
15:11
10/29/20
15:11
NFLX

Netflix

$484.61 /

-1.26 (-0.26%)

Shares of Netflix are up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$484.61 /

-1.26 (-0.26%)

NFLX Netflix
$484.61 /

-1.26 (-0.26%)

10/26/20 Wells Fargo
Netflix narrative to focus less on subs, more on profitability, says Wells Fargo
10/21/20 JPMorgan
Netflix weakness on earnings a buying opportunity, says JPMorgan
10/21/20 KeyBanc
KeyBanc sees Netflix stock weakness as 'an overreaction'
10/21/20 Wells Fargo
Netflix price target raised to $510 from $470 at Wells Fargo
NFLX Netflix
$484.61 /

-1.26 (-0.26%)

NFLX Netflix
$484.61 /

-1.26 (-0.26%)

NFLX Netflix
$484.61 /

-1.26 (-0.26%)

NFLX Netflix
$484.61 /

-1.26 (-0.26%)

Periodicals
Netflix raises prices for U.S. subscribers, Verge says » 15:05
10/29/20
10/29
15:05
10/29/20
15:05
NFLX

Netflix

$484.76 /

-1.11 (-0.23%)

Netflix is increasing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$484.76 /

-1.11 (-0.23%)

NFLX Netflix
$484.76 /

-1.11 (-0.23%)

10/26/20 Wells Fargo
Netflix narrative to focus less on subs, more on profitability, says Wells Fargo
10/21/20 JPMorgan
Netflix weakness on earnings a buying opportunity, says JPMorgan
10/21/20 KeyBanc
KeyBanc sees Netflix stock weakness as 'an overreaction'
10/21/20 Wells Fargo
Netflix price target raised to $510 from $470 at Wells Fargo
NFLX Netflix
$484.76 /

-1.11 (-0.23%)

NFLX Netflix
$484.76 /

-1.11 (-0.23%)

NFLX Netflix
$484.76 /

-1.11 (-0.23%)

NFLX Netflix
$484.76 /

-1.11 (-0.23%)

Options
Opko Health options imply 26.7% move in share price post-earnings » 15:04
10/29/20
10/29
15:04
10/29/20
15:04
OPK

Opko Health

$4.18 /

+0.175 (+4.38%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPK Opko Health
$4.18 /

+0.175 (+4.38%)

OPK Opko Health
$4.18 /

+0.175 (+4.38%)

07/31/20 Piper Sandler
Opko Health price target raised to $10 from $6 at Piper Sandler
07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
06/09/20 Piper Sandler
Opko Health price target raised to $4 from $3 at Piper Sandler
06/08/20 Piper Sandler
Opko Health, Pfizer data show IGF-1 normal at ENDO, says Piper Sandler
OPK Opko Health
$4.18 /

+0.175 (+4.38%)

OPK Opko Health
$4.18 /

+0.175 (+4.38%)

OPK Opko Health
$4.18 /

+0.175 (+4.38%)

OPK Opko Health
$4.18 /

+0.175 (+4.38%)

Hot Stocks
Horizon Therapeutics expands partnership with AGC Biologics » 15:02
10/29/20
10/29
15:02
10/29/20
15:02
HZNP

Horizon Therapeutics

$78.06 /

+0.65 (+0.84%)

AGC Biologics, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HZNP Horizon Therapeutics
$78.06 /

+0.65 (+0.84%)

HZNP Horizon Therapeutics
$78.06 /

+0.65 (+0.84%)

10/14/20 Stifel
Horizon expected to meet or exceed Q3, 2020 expectations, says Stifel
10/01/20 Stifel
Stifel halves Selecta Biosciences target to $2, sees 'no reason to buy here'
09/09/20 JPMorgan
Horizon Therapeutics initiated with an Overweight at JPMorgan
08/27/20
Fly Intel: Top five analyst initiations
HZNP Horizon Therapeutics
$78.06 /

+0.65 (+0.84%)

  • 07
    Aug
HZNP Horizon Therapeutics
$78.06 /

+0.65 (+0.84%)

Recommendations
Shopify price target raised to $1,323 at Goldman Sachs after 'impressive' Q3 » 14:56
10/29/20
10/29
14:56
10/29/20
14:56
SHOP

Shopify

$996.89 /

-27.59 (-2.69%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHOP Shopify
$996.89 /

-27.59 (-2.69%)

SHOP Shopify
$996.89 /

-27.59 (-2.69%)

14:39 Today Piper Sandler
Piper says Shopify added more merchants in Q3 than in last 8 quarters combined
13:57 Today Oppenheimer
Holiday discretionary spending 'a big question' for Shopify, says Oppenheimer
13:46 Today RBC Capital
Shopify price target raised to $1,290 from $1,250 at RBC Capital
12:59 Today Baird
Shopify price target raised to $1,250 from $1,200 at Baird
SHOP Shopify
$996.89 /

-27.59 (-2.69%)

  • 16
    Sep
  • 08
    May
SHOP Shopify
$996.89 /

-27.59 (-2.69%)

SHOP Shopify
$996.89 /

-27.59 (-2.69%)

SHOP Shopify
$996.89 /

-27.59 (-2.69%)

Options
Twitter options imply 21.7% move in share price post-earnings » 14:49
10/29/20
10/29
14:49
10/29/20
14:49
TWTR

Twitter

$52.50 /

+3.97 (+8.18%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$52.50 /

+3.97 (+8.18%)

TWTR Twitter
$52.50 /

+3.97 (+8.18%)

10/27/20 BofA
Twitter price target raised to $58 from $52 at BofA
10/27/20 JPMorgan
Twitter price target raised to $52 from $39 at JPMorgan
10/26/20 Wedbush
Twitter price target raised to $47 from $37.50 at Wedbush
10/26/20 Mizuho
Twitter price target raised to $45 from $40 at Mizuho
TWTR Twitter
$52.50 /

+3.97 (+8.18%)

TWTR Twitter
$52.50 /

+3.97 (+8.18%)

TWTR Twitter
$52.50 /

+3.97 (+8.18%)

TWTR Twitter
$52.50 /

+3.97 (+8.18%)

Periodicals
White House proceeds with sale of 50 F-35 planes to UAE, Reuters says » 14:48
10/29/20
10/29
14:48
10/29/20
14:48
LMT

Lockheed Martin

$354.51 /

+3.84 (+1.10%)

The White House informed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$354.51 /

+3.84 (+1.10%)

LMT Lockheed Martin
$354.51 /

+3.84 (+1.10%)

10/21/20 RBC Capital
Lockheed Martin price target raised to $414 from $405 at RBC Capital
09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/08/20 Morgan Stanley
Lockheed Martin initiated with an Overweight at Morgan Stanley
07/24/20 Argus
Lockheed Martin price target raised to $450 from $425 at Argus
LMT Lockheed Martin
$354.51 /

+3.84 (+1.10%)

LMT Lockheed Martin
$354.51 /

+3.84 (+1.10%)

LMT Lockheed Martin
$354.51 /

+3.84 (+1.10%)

Conference/Events
UBS consumer goods analyst to hold analyst/industry conference call » 14:43
10/29/20
10/29
14:43
10/29/20
14:43

Consumer Goods Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Treasury Action: yields have continued to climb higher as risk appetite returns » 14:40
10/29/20
10/29
14:40
10/29/20
14:40

Treasury Action: yields…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Piper says Shopify added more merchants in Q3 than in last 8 quarters combined » 14:39
10/29/20
10/29
14:39
10/29/20
14:39
SHOP

Shopify

$995.00 /

-29.48 (-2.88%)

Driven in part by the end…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHOP Shopify
$995.00 /

-29.48 (-2.88%)

SHOP Shopify
$995.00 /

-29.48 (-2.88%)

13:57 Today Oppenheimer
Holiday discretionary spending 'a big question' for Shopify, says Oppenheimer
13:46 Today RBC Capital
Shopify price target raised to $1,290 from $1,250 at RBC Capital
12:59 Today Baird
Shopify price target raised to $1,250 from $1,200 at Baird
10/14/20 Roth Capital
Shopify price target raised to $1,000 from $850 at Roth Capital
SHOP Shopify
$995.00 /

-29.48 (-2.88%)

  • 16
    Sep
  • 08
    May
SHOP Shopify
$995.00 /

-29.48 (-2.88%)

SHOP Shopify
$995.00 /

-29.48 (-2.88%)

SHOP Shopify
$995.00 /

-29.48 (-2.88%)

Conference/Events
UBS financials/fintech analysts hold analyst/industry conference call » 14:39
10/29/20
10/29
14:39
10/29/20
14:39

Financial Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

On The Fly
Fly Intel: What to watch in Amazon earnings report » 14:38
10/29/20
10/29
14:38
10/29/20
14:38
AMZN

Amazon.com

$3,246.00 /

+82.83 (+2.62%)

Amazon (AMZN) is…

ShowHide Related Items >><<
AMZN Amazon.com
$3,246.00 /

+82.83 (+2.62%)

AMZN Amazon.com
$3,246.00 /

+82.83 (+2.62%)

10/27/20 Credit Suisse
Amazon.com price target raised to $3,700 from $3,680 at Credit Suisse
10/27/20 KeyBanc
Tapestry price target raised to $27 from $20 at KeyBanc
10/27/20 Deutsche Bank
Amazon.com price target raised to $4,050 from $4,000 at Deutsche Bank
10/26/20 Wedbush
Wedbush expects Amazon to report Q3 sales upside, record Q4
AMZN Amazon.com
$3,246.00 /

+82.83 (+2.62%)

AMZN Amazon.com
$3,246.00 /

+82.83 (+2.62%)

AMZN Amazon.com
$3,246.00 /

+82.83 (+2.62%)

AMZN Amazon.com
$3,246.00 /

+82.83 (+2.62%)

AMZN Amazon.com
$3,246.00 /

+82.83 (+2.62%)

Conference/Events
UBS industrials analyst to hold analyst/industry conference call » 14:36
10/29/20
10/29
14:36
10/29/20
14:36

Industrials Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Straumann price target lowered to CHF 716 from CHF 754 at JPMorgan » 14:27
10/29/20
10/29
14:27
10/29/20
14:27
SAUHY

Straumann

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAUHY Straumann
$0.00 /

+ (+0.00%)

14:17 Today UBS
Straumann price target raised to CHF 910 from CHF 890 at UBS
10/14/20 Berenberg
Straumann price target raised to CHF 850 from CHF 770 at Berenberg
10/06/20 Deutsche Bank
Straumann price target raised to CHF 940 from CHF 920 at Deutsche Bank
10/05/20 JPMorgan
Straumann price target raised to CHF 754 from CHF 668 at JPMorgan
Recommendations
Beiersdorf price target lowered to EUR 95 from EUR 98 at JPMorgan » 14:27
10/29/20
10/29
14:27
10/29/20
14:27
BDRFY

Beiersdorf

$0.00 /

+ (+0.00%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDRFY Beiersdorf
$0.00 /

+ (+0.00%)

14:18 Today UBS
Beiersdorf price target lowered to EUR 84 from EUR 85 at UBS
12:53 Today Barclays
Beiersdorf price target lowered to EUR 113 from EUR 115 at Barclays
12:03 Today RBC Capital
Beiersdorf price target raised to EUR 100 from EUR 98 at RBC Capital
05:45 Today HSBC
Beiersdorf downgraded to Hold from Buy at HSBC
Recommendations
SKF AB price target raised to SEK 190 from SEK 180 at JPMorgan » 14:26
10/29/20
10/29
14:26
10/29/20
14:26
SKFRY

SKF AB

$0.00 /

+ (+0.00%)

JPMorgan analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SKFRY SKF AB
$0.00 /

+ (+0.00%)

10/28/20 Morgan Stanley
SKF AB price target raised to SEK 192 from SEK 180 at Morgan Stanley
10/28/20 Deutsche Bank
SKF AB price target raised to SEK 200 from SEK 170 at Deutsche Bank
10/14/20 Barclays
SKF AB upgraded to Equal Weight from Underweight at Barclays
10/02/20 Goldman Sachs
SKF AB price target raised to SEK 231 from SEK 224 at Goldman Sachs

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.